255 related articles for article (PubMed ID: 33810275)
41. Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy.
Sun M; Hao Pontius MH; Yang S; Pendekanti T; Raghunathan S; Shavit JA; Sen Gupta A
J Thromb Haemost; 2023 Apr; 21(4):983-994. PubMed ID: 36696210
[TBL] [Abstract][Full Text] [Related]
42. Activation of the fibrinolytic system.
Robison AK; Collen D
Cardiol Clin; 1987 Feb; 5(1):13-9. PubMed ID: 3103919
[TBL] [Abstract][Full Text] [Related]
43. Fibrin and fibrinolysis in infection and host defense.
Degen JL; Bugge TH; Goguen JD
J Thromb Haemost; 2007 Jul; 5 Suppl 1():24-31. PubMed ID: 17635705
[TBL] [Abstract][Full Text] [Related]
44. Plasminogen and plasmin can bind to human T cells and generate truncated CCL21 that increases dendritic cell chemotactic responses.
Loef EJ; Sheppard HM; Birch NP; Dunbar PR
J Biol Chem; 2022 Jul; 298(7):102112. PubMed ID: 35690148
[TBL] [Abstract][Full Text] [Related]
45. Bacterial plasminogen activators and receptors.
Lähteenmäki K; Kuusela P; Korhonen TK
FEMS Microbiol Rev; 2001 Dec; 25(5):531-52. PubMed ID: 11742690
[TBL] [Abstract][Full Text] [Related]
46. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
Pannell R; Black J; Gurewich V
J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
[TBL] [Abstract][Full Text] [Related]
47. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
[TBL] [Abstract][Full Text] [Related]
48. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
Ries M; Zenker M; Gaffney PJ
Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
[TBL] [Abstract][Full Text] [Related]
49. Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro.
Fredenburgh JC; Nesheim ME
J Biol Chem; 1992 Dec; 267(36):26150-6. PubMed ID: 1464625
[TBL] [Abstract][Full Text] [Related]
50. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
Sakata Y; Aoki N
J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
[TBL] [Abstract][Full Text] [Related]
51. Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity.
Ajjan RA; Gamlen T; Standeven KF; Mughal S; Hess K; Smith KA; Dunn EJ; Anwar MM; Rabbani N; Thornalley PJ; Philippou H; Grant PJ
Blood; 2013 Jul; 122(1):134-42. PubMed ID: 23699598
[TBL] [Abstract][Full Text] [Related]
52. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.
Chapman HA; Vavrin Z; Hibbs JB
Cell; 1982 Mar; 28(3):653-62. PubMed ID: 6210439
[TBL] [Abstract][Full Text] [Related]
53. Fibrinolytic enzyme in the lining walls of chronic subdural hematoma.
Ito H; Komai T; Yamamoto S
J Neurosurg; 1978 Feb; 48(2):197-200. PubMed ID: 146730
[TBL] [Abstract][Full Text] [Related]
54. Intersection of Coagulation and Fibrinolysis by the Glycosylphosphatidylinositol (GPI)-Anchored Serine Protease Testisin.
Buzza MS; Pawar NR; Strong AA; Antalis TM
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298257
[TBL] [Abstract][Full Text] [Related]
55. Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma.
Talbot K; Meixner SC; Pryzdial EL
Biochim Biophys Acta; 2013 Jun; 1834(6):989-95. PubMed ID: 23416531
[TBL] [Abstract][Full Text] [Related]
56. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
[TBL] [Abstract][Full Text] [Related]
57. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
58. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
[TBL] [Abstract][Full Text] [Related]
59. The human plasma fibrinolytic system: regulation and control.
Robbins KC
Mol Cell Biochem; 1978 Aug; 20(3):149-57. PubMed ID: 151804
[TBL] [Abstract][Full Text] [Related]
60. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin.
Mutch NJ; Engel R; Uitte de Willige S; Philippou H; Ariëns RA
Blood; 2010 May; 115(19):3980-8. PubMed ID: 20228273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
